| # | Drug | Count |
|---|---|---|
| 0 | MACITENTAN | 7 |
| 1 | SILDENAFIL | 7 |
| 2 | SILDENAFIL CITRATE | 7 |
| 3 | SILDENAFIL POWDER, | 6 |
| 4 | TACROLIMUS | 6 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 6 | TACROLIMUS OINTMENT 0.1% | 6 |
| 7 | ATEZOLIZUMAB | 1 |
| 8 | BEVACIZUMAB | 1 |
| 9 | CERTOLIZUMAB PEGOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 1 | 0.0011 |
| 1 | SILDENAFIL POWDER, | 6 | 0.0002 |
| 2 | MACITENTAN | 7 | 0.0001 |
| 3 | SILDENAFIL CITRATE | 7 | 0.0001 |
| 4 | TACROLIMUS OINTMENT 0.1% | 6 | 0.0000 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 | 0.0000 |
| 6 | TACROLIMUS | 6 | 0.0000 |
| 7 | LENVATINIB | 1 | 0.0000 |
| 8 | ATEZOLIZUMAB | 1 | 0.0000 |
| 9 | OXALIPLATIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 6 | 0.0000 |
| 2 | Endothelin Receptor Antagonist [EPC] | 7 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Prostacycline Vasodilator [EPC] | 1 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |